Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
After finishing at $20.96 in the prior trading day, Syndax Pharmaceuticals Inc (NASDAQ: SNDX) closed at $20.97, up 0.05%. In other words, the price has increased by $0.05 from its previous closing price. On the day, 0.87 million shares were traded. SNDX stock price reached its highest trading level at $21.54 during the session, while it also had its lowest trading level at $20.91.
Ratios:
Our goal is to gain a better understanding of SNDX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 10.00 and its Current Ratio is at 10.00. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Scotiabank on January 31, 2024, Downgraded its rating to Sector Perform and sets its target price to $23 from $36 previously.
On December 22, 2023, Mizuho started tracking the stock assigning a Buy rating and target price of $45.
On October 25, 2023, BofA Securities started tracking the stock assigning a Buy rating and target price of $29.BofA Securities initiated its Buy rating on October 25, 2023, with a $29 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 09 ’23 when Morrison Briggs sold 52,855 shares for $18.27 per share. The transaction valued at 965,402 led to the insider holds 17,836 shares of the business.
Meury William sold 83,000 shares of SNDX for $1,697,810 on Aug 02 ’23. The Director now owns 48,000 shares after completing the transaction at $20.46 per share. On Jul 10 ’23, another insider, Morrison Briggs, who serves as the Director of the company, sold 52,855 shares for $20.40 each. As a result, the insider received 1,078,068 and left with 17,836 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNDX now has a Market Capitalization of 1782024192 and an Enterprise Value of 1204928640.
Stock Price History:
Over the past 52 weeks, SNDX has reached a high of $25.34, while it has fallen to a 52-week low of $11.22. The 50-Day Moving Average of the stock is -7.77%, while the 200-Day Moving Average is calculated to be 10.01%.
Shares Statistics:
The stock has traded on average 1.17M shares per day over the past 3-months and 954700 shares per day over the last 10 days, according to various share statistics. A total of 84.83M shares are outstanding, with a floating share count of 80.62M. Insiders hold about 5.11% of the company’s shares, while institutions hold 100.47% stake in the company. Shares short for SNDX as of 1711584000 were 9620763 with a Short Ratio of 8.22, compared to 1709164800 on 9089869. Therefore, it implies a Short% of Shares Outstanding of 9620763 and a Short% of Float of 11.41.
